Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02723019 · ClinicalTrials.gov registry record · NA
Mi Puente: My Bridge to Better Cardiometabolic Health and Well-Being
A NA study of Type 2 Diabetes Mellitus and Behavioral Health Concerns, sponsored by Scripps Whittier Diabetes Institute.
- Completed
- Registry status
- NA
- Development phase
- 536
- Enrollment target
- 1
- Study location
NCT02723019 is a NA study of Type 2 Diabetes Mellitus and Behavioral Health Concerns that has completed, run by Scripps Whittier Diabetes Institute. The registered enrollment target is 536 participants, below the 2,744-participant average among 122 other Type 2 Diabetes Mellitus trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02723019, a NA study of Type 2 Diabetes Mellitus and Behavioral Health Concerns, has completed, sponsored by Scripps Whittier Diabetes Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 536 participants
- Enrollment target
- 1
- Study location
Study Summary
Mi Puente (or "My Bridge") is a culturally-tailored, interdisciplinary approach designed to support at-risk Hispanic patients and their caregivers pre- and post-hospital discharge as they navigate the multi-level barriers that contribute to inequities in health care access and use, and in turn, perpetuate disparities in cardiometabolic and behavioral health. Mi Puente utilizes a sustainable nurse + volunteer peer team-based model, bridging partnership between inpatient and outpatient care settings to meet the integrated (i.e., physical and behavioral) health needs of Hispanics who are hospitalized with multiple chronic cardiometabolic conditions and one or more behavioral health concern(s). Participants will be tested at Scripps Mercy Hospital - a large, non-profit, safety net hospital located in the US/Mexico border region of South San Diego County, California. The proposed randomized controlled trial will test Mi Puente versus Usual Care (evidence-based, best practice discharge procedures) in improving hospital utilization, patient-reported, and cost effectiveness outcomes. Electronic medical records (EMR) will be used to identify eligible patients and examine primary outcomes.
Conditions Studied
Interventions
- BEHAVIORAL Volunteer Peer Mentor+Behavioral Health Nurse
Study Locations (1)
California
- Scripps Mercy Chula Vista - Chula Vista
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 536 participants |
| Start Date | 2016-07-14 |
| Est. Completion | 2020-11-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02723019
The ClinicalTrials.gov registry entry for NCT02723019 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 536 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,744-participant average among 122 other Type 2 Diabetes Mellitus trials with a reported enrollment target (80% lower). The listed sponsor is Scripps Whittier Diabetes Institute, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Type 2 Diabetes Mellitus appearing as the primary indexed condition, and to 1 intervention - of which Volunteer Peer Mentor+Behavioral Health Nurse is the first listed.
NCT02723019 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT02723019 about?
NCT02723019 is a clinical study titled "Mi Puente: My Bridge to Better Cardiometabolic Health and Well-Being". Mi Puente (or "My Bridge") is a culturally-tailored, interdisciplinary approach designed to support at-risk Hispanic patients and their caregivers pre- and post-hospital discharge as they navigate the multi-level barriers that contribute to inequities in health care access and use, and in turn, perp...
What is the current status of trial NCT02723019?
This trial is currently completed. It is a NA study. The enrollment target is 536 participants. The study started on 2016-07-14. Estimated completion is 2020-11-30.
What conditions does trial NCT02723019 study?
This clinical trial studies the following conditions: Type 2 Diabetes Mellitus, Behavioral Health Concerns, Cardiometabolic Conditions.
What interventions are being tested in trial NCT02723019?
The interventions under investigation include: Volunteer Peer Mentor+Behavioral Health Nurse (BEHAVIORAL).
Who is sponsoring clinical trial NCT02723019?
This trial is sponsored by Scripps Whittier Diabetes Institute, which has 17 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02723019 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 2 Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Preventing Type 2 Diabetes in Black Emergent Adult
RECRUITING · NA
-
The GRoceries Aimed at Increasing Nutrition Study
RECRUITING · NA
-
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
RECRUITING · NA
-
Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes
RECRUITING · NA
-
Impact of Metabolic Health on Sperm Epigenetic Marks in Humans
ACTIVE NOT RECRUITING · NA
-
Is the Degree of Perceived Effort During Resistance Exercise Important for Improvements in Blood Glucose
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.